The pharmaceutical industry has worked well together to ensure continuity of supply
of important Pharmaceutical Benefits Scheme (PBS) medicines at the time of
significant price changes on 1 April. Many manufacturers, wholesalers and
community pharmacies have contributed to ensure uninterrupted supply of PBS
The broad industry places a priority on serving patients’ medication needs.
The significant price reductions for many PBS medicines to take place on 1 April –
the largest set of reductions in the history of the PBS – created stock management
challenges for all pharmacies, wholesalers, and manufacturers.
Fortunately, many pharmaceutical companies – including a number of branded
medicines companies and virtually every generic medicine company – have risen to
the challenge and reduced their prices in the supply chain well ahead of 1 April, to
avoid any supply disruption.
For more details, please Click